AzTrials
AzTrials

StrokeNCT03062930

Remediation of the Non-Paretic Arm in Stroke

A study testing Track 1 and Track 2 in people with Stroke, run by Milton S. Hershey Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Stroke survivors with severe contralesional paresis often have substantial control and coordination deficits in the non-paretic arm. Because this arm must serve as the primary controller, these deficits can be functionally devastating. Read more about this study

Who is it for?
Ages 21 to 85 years
Conditions the study is for
Stroke
What is being tested?
Track 1 and Track 2
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
15 participants
Where
1 siteUnited States
Study dates
20 Aug 2016to 1 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects will be between 21 and 85 years old of either gender
  • Subjects will demonstrate cognitive abilities required to follow commands and engage in the experimental task
  • Subjects will have had a unilateral stroke at least 3 months prior to participation resulting in upper extremity motor deficits

Who cannot join

  • hospitalization for substance abuse and/or a major psychiatric diagnosis (schizophrenia);
  • non-stroke neurological diseases that may affect ability to perform task or upper limb motor function
  • certain peripheral movement restrictions, such as neuropathy
  • neuroradiological confirmation of concomitant damage to the cerebellum or brain stem or extensive periventricular white matter changes (based on consultation with neuroradiology)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Penn State College of Medicine; Hershey Medical Center

    Hershey, Pennsylvania, 17033

Other trials in United States

About this study

Official title: Remediation of the Non-Paretic Arm to Improve Functional Independence in Chronic Stroke Survivors

Stroke survivors with severe contralesional paresis often have substantial control and coordination deficits in the non-paretic arm. Because this arm must serve as the primary controller, these deficits can be functionally devastating. The investigators now hypothesize that the combination of severe paresis (Upper Extremity Fugl-Meyer Score ≤35) and persistent motor deficits in the non-paretic arm limits functional independence in chronic stroke survivors. The investigators predict that remediation, focused on the non-paretic arm should improve functional independence. The investigators propose a randomized study design with two tracts, two periods and four assessments. The investigators envision this study as the first step in establishing the basis for a rehabilitation approach that focuses on remediation of BOTH arms, which constitutes a substantial change from current remediation protocols focused only on the contralesional arm.

Read the detailed description

The investigators previously elaborated hemisphere specific motor deficits in the non-paretic arm of chronic stroke survivors with unilateral hemisphere damage. The investigators showed that these deficits are associated with substantial limitations in performance of activities of daily living (ADL), an effect exacerbated by contralesional paresis due to forced reliance on the non-paretic arm. The investigators now hypothesize that the combination low moderate to severe paresis (Fugl-Meyer Score < 35) and persistent motor deficits in the non-paretic arm limits functional independence in chronic stroke survivors. The investigators predict that intense remediation focused on improving the speed, coordination, and accuracy of the non-paretic arm should improve functional independence, as well as improving paretic arm function due to increased participation in daily activities. Unfortunately, the usual standard of care in rehabilitation for survivors with low-moderate to severe paresis tends to focus on task training in essential ADL activities, rather than on intensive remediation. Previous research has shown that non-paretic arm deficits depend on the hemisphere that is damaged by stroke, such that left hemisphere damage (LHD) impairs trajectory features, including speed and smoothness, while right hemisphere damage (RHD) impairs the ability to bring the arm to rest at an accurate and stable position. The investigators have designed a training program to address both of these motor components and to improve the speed and dexterity of the non-paretic arm. The investigators propose a randomized study design with two tracts, two periods and four assessments. Participants will first complete 2 baseline assessments, spaced 3 weeks apart. Following completion of the second assessment, participants will be randomly assigned to one of two tracks: Track 1 will receive three weeks of arm training, followed by 3 weeks of a comparison condition. Participants assigned to track 2 will receive three weeks of the comparison condition, followed by 3 weeks of arm training. Then, all participants will complete an end-of-period assessment, and a follow-up assessment for retention, 3 weeks after completion of the two periods. Pilot results indicate that non-paretic arm training produces substantial improvements in motor performance and functional independence as well as reducing paretic arm impairment. This is an essential first-step in developing a rehabilitation protocol focused on remediating both arms of severely impaired stroke survivors.

Conditions
Stroke
Being tested
Track 1, Track 2
Keywords
stroke, hemiparesis, lesion hemisphere, ipsilesional deficits, contralesional deficits, rehabilitation, remediation, paretic arm
Medical subject headings
Stroke, Paresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Track 1Behavioural

    Also called remediation of non-paretic arm followed by sham training

    Training of non-paretic arm followed by sham condition

  • Track 2Behavioural

    Also called sham condition followed by remediation of non-paretic arm

    Same procedures as track 1, but completed in opposite order, starting with sham condition followed by the non-paretic arm training

Study groups in NCT03062930
Study groupRoleWhat they receive
Track 1Active comparatorTraining of non-paretic arm for 3 weeks consisting of occupational therapy and kinematic tasks followed by sham condition (playing board games/computer games) for 3 weeks
Receives: Behavioral: Track 1; Behavioral: Track 2
Track 2Sham comparatorSham condition (playing board games/computer games) for 3 weeks followed by training of the non-paretic arm for 3 weeks consisting of occupational therapy and kinematic tasks
Receives: Behavioral: Track 1; Behavioral: Track 2

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in performance time on Jebsen Taylor Hand Function Test

    test of unimanual arm function on the non-paretic arm

    Measured: week -3, week 0, week 3, week 6, week 9

Secondary outcomes (4)
  1. Change in Barthel Index

    measure of functional independence

    Measured: week -3, week 0, week 3, week 6, week 9

  2. Change in Kinematic analysis

    Distance and Direction Errors and Hand Path Straightness on virtual reaching task (non-paretic arm)

    Measured: week -3, week 0, week 3, week 6, week 9

  3. Change in Grooved Pegboard

    timed measure of dexterity of the non-paretic arm

    Measured: week -3, week 0, week 3, week 6, week 9

  4. Change in Upper Extremity Fugl Meyer Assessment

    test of paretic arm function

    Measured: week -3, week 0, week 3, week 6, week 9

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2017
  2. Study start20 Aug 2016
  3. Primary completion1 Dec 2018
  4. Study completion1 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03062930
Sponsor's protocol ID
STUDY00002937
Other IDs
16GRNT31010001
Status last verified
Mar 2019
First submitted
20 Oct 2016
Last updated
28 Mar 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: Scholar Sphere

Questions about this trial

What is this clinical trial studying?

A study testing Track 1 and Track 2 in people with Stroke, run by Milton S. Hershey Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in performance time on Jebsen Taylor Hand Function Test (time frame: week -3, week 0, week 3, week 6, week 9). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in